Thyroid Cancer
Conditions
Interventions
Observation group:None
Sponsors
Sulaimani university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients were eligible for inclusion if they had a histopathologically confirmed diagnosis of PTC, underwent total thyroidectomy during the study period, and had available formalin-fixed, paraffin-embedded (FFPE) tumor tissue suitable for molecular analysis. Only cases with complete clinicopathological data, including demographic, biochemical, and tumor-related parameters, were enrolled.
Exclusion criteria
Exclusion criteria: Patients were excluded if they had any other histological type of thyroid cancer, presented with distant metastasis at the time of diagnosis, or had insufficient or poor-quality FFPE samples that failed DNA extraction or sequencing quality control. Individuals with recurrent thyroid cancer, previous thyroid surgery, radiotherapy, or systemic therapy were also excluded, as well as cases with incomplete medical records that could not be used for statistical evaluation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of BRAF mutation; | — |
Countries
IRAQ
Contacts
Public ContactRawezh Qadir M Salih
Sulaimani university
Outcome results
None listed